Quick Answer
Pelthos Therapeutics Inc. reported Net Income of -$43.32 million for fiscal year 2025.
Pelthos Therapeutics Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$43.32M | -444.6% |
| 2024 | -$7.96M | -7.8% |
| 2023 | -$7.38M | -200.2% |
| 2022 | -$2.46M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$16.24M | -858.0% | -370.8% |
| June 30, 2025 | -$3.45M | -94.6% | -75.3% |
| March 31, 2025 | -$1.97M | +23.2% | -16.1% |
| September 30, 2024 | -$1.70M | -19.2% | +4.3% |
| June 30, 2024 | -$1.77M | -85.9% | +30.8% |
| March 31, 2024 | -$2.56M | -165.1% | -80.2% |
| September 30, 2023 | -$1.42M | — | -49.1% |
| June 30, 2023 | -$953.3K | — | +1.4% |
- Pelthos Therapeutics Inc. showed a decrease of -444.6% in Net Income compared to the prior fiscal year.
- Over the 2022–2025 period, Pelthos Therapeutics Inc.’s net income has declined by 1661.9% (from -$2.46 million to -$43.32 million).
- The most recent figure is from Pelthos Therapeutics Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 19, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: